1.Current Research Status,Challenges,Differentiation and Treatment Strategies of Traditional Chinese Medicine for Gastroesophageal Reflux Disease
Fengyun WANG ; Mi LYU ; Bingduo ZHOU ; Beihua ZHANG ; Yi WANG ; Tingting XU ; Cong HE ; Xiaokang WANG ; Xin LIU ; Yang WANG ; Kaiyue HUANG ; Lusi XU ; Xudong TANG
Journal of Traditional Chinese Medicine 2026;67(4):392-396
This article systematically reviews the current research status as well as diagnosis and treatment strategies of traditional Chinese medicine (TCM) for gastroesophageal reflux disease (GERD). Studies demonstrate that TCM, based on the "disease-syndrome combination" approach, exhibits multi-target advantages in alleviating symptoms of various GERD subtypes, promoting mucosal repair, regulating emotions, and facilitating the reduction of western medication. To address clinical challenges such as symptom overlap and limited therapeutic efficacy, strategies have been proposed including "treating different diseases with the same method" and integrated regulation based on viscera correlation. Future efforts should focus on elucidating the mechanisms of compound prescriptions, promoting TCM drug development under the "three-combination" evaluation framework that integrates TCM theory, human experience and clinical trial evidence, and optimizing integrated traditional and western medicine models to enhance GERD management.
2.Mechanism of Wendan Ningxin Granules in Modulating Diastolic Calcium Leakage-related Proteins to Improve Inflammation-associated Atrial Fibrillation Susceptibility
Biyue SHANG ; Tingting ZHU ; Shunxin LYU ; Zhiwei ZHANG ; Yufei WANG ; Xiangning CUI ; Yingdong LU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(11):133-143
ObjectiveTo investigate the protective effect and mechanism of Wendan Ningxin granules (WNG) on susceptibility to atrial fibrillation (AF) in mice with inflammatory injury. Methods100 C57BL/6 mice were divided into a blank control group, a model group, a low-dose WNG group (2.34 g·kg-1·d-1), a high-dose WNG group (4.68 g·kg-1·d-1), and an amiodarone positive control group (0.091 g·kg-1·d-1), with 20 mice in each group. Except for the blank control group, mice in other groups received intraperitoneal injections of lipopolysaccharide (LPS) to establish an inflammatory injury model. Treatment groups received continuous intragastric administration of their respective interventions for four weeks. During the fourth week, the treatment groups received LPS injections concurrently with their treatments. The blank control and model groups received distilled water (10 mL·kg-1·d-1) by gavage, with a gavage volume of 10 mL·kg-1 for all groups, once daily. Hematoxylin-eosin (HE) staining and Sirius red staining were used to observe atrial tissue morphology and fibrosis degree. Immunohistochemistry was used to assess the expression of α-smooth muscle actin (α-SMA) in mouse atrial tissue. Electrophysiological detection was performed using a multi-channel electrophysiology mapping system to measure AF inducibility, AF duration, and atrial effective refractory period (AERP). High-resolution optical mapping was used to measure action potential duration (APD) dispersion, conduction heterogeneity index, and calcium transient (CaT) dispersion. Real-time quantitative polymerase chain reaction (Real-time PCR) was used to detect mRNA expression of proteins related to diastolic calcium leakage in mouse atria: Ca2+/calmodulin-dependent protein kinase Ⅱ(CaMKⅡ), ryanodine receptor 2(RyR2), sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA), and sodium-calcium exchanger (NCX). Western blot analysis was performed to detect the expression of CaMKII, RyR2, SERCA, and NCX proteins in myocardial tissue from each group. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of inflammatory factors interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). ResultsPathological staining results showed that compared with the blank control group, the model group exhibited disrupted atrial tissue structure, inflammatory cell infiltration, atrial fibrosis, and diffuse infiltration of numerous brown α-SMA positive cells in the atrial interstitium (P<0.01). AF could be induced by electrical stimulation with a longer duration. AERP was shortened, while APD dispersion, conduction heterogeneity index, and CaT dispersion were increased (P<0.01). The expression of proteins associated with diastolic calcium leakage, including CaMKⅡ, RyR2, and NCX1, showed elevated mRNA and protein levels, whereas SERCA2a mRNA and protein expression decreased (P<0.05). Serum levels of inflammatory factors IL-1β and TNF-α were elevated (P<0.01). Compared with the model group, intervention with WNG alleviated cardiac structural damage, reduced inflammatory cell infiltration, improved atrial fibrosis, and reduced the diffuse infiltration of α-SMA positive cells (P<0.01). AF inducibility and AF duration upon electrical stimulation were significantly reduced (P<0.05), AERP was prolonged (P<0.05), mRNA and protein expression of CaMKⅡ, RyR2, and NCX1-proteins associated with diastolic calcium leakage-were reduced, whilst mRNA and protein expression of SERCA2a increased (P<0.05), and serum levels of IL-1β and TNF-α were decreased (P<0.01). ConclusionBoth low‑ and high‑dose WNG can effectively reduce susceptibility to inflammation-related AF. The mechanism by which WNG reduce AF susceptibility may be related to regulating proteins involved in sarcoplasmic reticulum diastolic calcium leak, thereby improving cardiac electrical remodeling, and alleviating inflammation-induced myocardial fibrosis, thus improving cardiac structural remodeling.
3.Effect of Modified Baoyuantang Combined with Linggui Zhugantang on Myocardial Mitochondrial Damage and NLRP3/GSDMD-mediated Pyroptosis in Rat Model of Post-myocardial Infarction Heart Failure
Tingting ZHU ; Lifei LYU ; Biyue SHANG ; Zhiwei ZHANG ; Shunxin LYU ; Yufei WANG ; Xiangning CUI ; Yingdong LU
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(17):1-12
ObjectiveTo investigate the therapeutic effects of modified Baoyuantang combined with Linggui Zhugantang on post-myocardial infarction heart failure in rats and its influence on NOD-like receptor pyrin domain-containing protein 3 (NLRP3)/gasdermin D (GSDMD)-mediated pyroptosis. MethodsSixty male SD rats were randomized into sham, model, low-, medium-, and high-dose (2.52, 5.04, 10.08 g·kg-1, respectively) modified Baoyuantang combined with Linggui Zhugantang, and sacubitril/valsartan sodium (0.021 g·kg-1) groups, with 10 rats in each group. Except the sham group, the other groups underwent left anterior descending coronary artery ligation for the modeling of myocardial infarction. The treatment groups were administrated with corresponding drugs by gavage, and the sham and model groups received an equal volume of normal saline. Administration began on the first day after successful modeling, once daily, for 4 weeks. Echocardiography was used to measure left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular end-diastolic and end-systolic diameters (LVIDd and LVIDs), left ventricular posterior wall thicknesses at end-diastole and end-systole (LVPWd, LVPWs), and left ventricular volumes at end-diastole and end-systole (LV Vold and LV Vols). Cardiac mass index and heart weight-to-tibia length ratio were calculated. Hematoxylin-eosin (HE) staining and Sirius Red staining were performed to observe myocardial morphology and collagen deposition. Immunohistochemistry was employed to detect the expression of type I collagen (Collagen Ⅰ), NLRP3, GSDMD, and interleukin-1β (IL-1β). Transmission electron microscopy was used to observe the mitochondrial ultrastructure. Tetramethylrhodamine methyl ester (TMRM) staining was conducted to assess mitochondrial membrane potential (MMP) in cardiomyocytes. Real-time PCR was used to quantify the mRNA levels of NLRP3, cysteinyl aspartate-specific proteinase-1 (Caspase-1), IL-1β, GSDMD, and interleukin-18 (IL-18) in the myocardial tissue. Western blotting was employed to determine the protein levels of NLRP3, Caspase-1, GSDMD, IL-1β, IL-18, nuclear factor kappa-B (NF-κB) p50, and NF-κB p65 in the myocardial tissue. Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the serum levels of tumor necrosis factor-α (TNF-α), IL-1β, and IL-6. ResultsCompared with the sham group, the model group showed increased LVIDd, LVIDs, LV Vold, LV Vols, cardiac mass index, and heart weight-to-tibia length ratio (P<0.05), decreased LVPWs, LVEF, LVFS, and MMP (P<0.05), evident myocardial inflammation, fibrosis, and mitochondrial damage, upregulated expression of NLRP3, Caspase-1, GSDMD, IL-1β, IL-18, NF-κB p50, and NF-κB p65, and elevated serum levels of TNF-α, IL-1β, and IL-6 (P<0.05). Compared with the model group, modified Baoyuantang combined with Linggui Zhugantang reduced the LVIDd, LVIDs, LV Vols, cardiac mass index, and heart weight-to-tibia length ratio (P<0.05), increased the LVPWs, LVEF, LVFS, and MMP (P<0.05), alleviated myocardial inflammation and fibrosis, improved the mitochondrial structure and function, downregulated the expression of NLRP3, Caspase-1, GSDMD, IL-1β, IL-18, NF-κB p50, and NF-κB p65 (P<0.05), and reduced the serum levels of TNF-α, IL-1β, and IL-6 (P<0.05). ConclusionModified Baoyuantang combined with Linggui Zhugantang can ameliorate post-myocardial infarction ventricular remodeling and improve the cardiac function by reducing mitochondrial damage and inhibiting NLRP3/GSDMD-mediated pyroptosis.
4.Cancer Incidence and Mortality in Anhui Cancer Regis-tration Areas in 2019 and Trends from 2015 to 2019
Huadong WANG ; Dan DAI ; Qiang ZHU ; Yili LYU ; Tingting DOU ; Weidong LI
China Cancer 2025;34(2):98-107
[Purpose]To analyze cancer incidence and mortality in Anhui cancer registration areas in 2019 and the trends from 2015 to 2019.[Methods]Data from 42 cancer registration areas in Anhui Province in 2019 meeting quality control requirements were collected.The incidence,mor-tality,age-standardized rates by Chinese standard population and world standard population,age-specific rate,accumulation rate(0~74 years old)and the top 10 cancers of high incidence and mortality were calculated by urban and rural areas,sexes and age groups.The standard population of China in 2000 was used for age-standardized incidence or mortality rate(ASIRC or ASMRC),and the Segi world standard population was used for age-standardized incidence or mortality rate(ASIRW or ASMRW),respectively.Joinpoint was used to analyze the incidence and mortality trends from 2015 to 2019,and the annual percentage change(APC)was estimated.[Results]In 2019,the reported incidence rate(crude rate)in Anhui cancer registration areas was 282.87/105(313.24/105 for male,251.19/105 for female),ASIRC and ASIRW were 183.85/105 and 178.94/105,respectively,with the cumulative incidence rate of 20.35%.There was no significant change in the incidence of malignant tumors from 2015 to 2019(APC=-1.00%,P>0.05).The reported mortality rate(crude rate)was 167.20/105(214.67/105 for male,117.67/105 for female),ASMRC and ASMRW were 98.41/105 and 97.15/105,and the cumulative mortality rate was 10.68%.There was no significant change in the mortality rate of malignant tumors from 2015 to 2019(APC=-3.44%,P>0.05).The incidence and mortality rate of lung cancer ranked the first in urban and rural popu-lations of all genders.The incidence rate of female breast cancer ranked the third and the mortali-ty rate ranked the sixth of all malignancies.The incidence and mortality of malignant tumors in men were higher than those in women,and higher in rural areas than those in urban areas,and the main cancer types of rural and urban areas tended to be the same.[Conclusion]From 2015 to 2019,there was no significant change in the incidence and mortality of malignant tumors in the cancer registration areas of Anhui Province,but it is still necessary to prevent and treat lung can-cer and female breast cancer.
5.Construction of risk evaluation system for safe operation of medical equipment of the department of pediatrics in hospital on the basis of comprehensive weight
Tingting LYU ; Lina SHI ; Xu WANG ; Xiaojie NING
China Medical Equipment 2025;22(4):123-128
Objective:To construct a risk evaluation system for safe operation of medical equipment of the department of pediatric internal medicine on the basis of comprehensive weight,so as to reduce the risk of operating equipment.Methods:The risk evaluation model of managing medical equipment was constructed by using Delphi method,and the evaluation indicators were weighted by analytic hierarchy process(AHP)and entropy weight method,and then,the safety management for equipment was conducted after the relative weights of indicators at each level were determined.A total of 100 used medical equipment in the department of pediatric internal medicine of Yuncheng Central Hospital of Shanxi Province from January 2022 to December 2023 were selected,and they were managed respectively by conventional management mode(50 equipment)and the management mode with risk evaluation system for safe operation of medical equipment(50 equipment).The quality of equipment operation,safety of clinical use and risk control rate of equipment alarm between the two management modes were compared,as well as the recognition scores of the engineers of equipment,doctors,paramedics and managers of relative department,who used and managed equipment,for the two management modes.Results:The average values of maintenance implementation rate,quality inspection qualification rate,disinfection qualification rate and effective response rate of problems of equipment of using the management mode with risk evaluation system were respectively(93.65±3.65)%,(91.45±3.25)%,(93.14±3.69)%and(94.26±3.14)%,which were all higher than these of conventional management mode,and the differences were statistically significant(t=18.599,12.376,11.746,16.006,P<0.05).The ratios of device-associated infection,stress injury and body fluid extravasation of risk events were respectively 4%(2/50),6%(3/50)and 6%(3/50),which were lower than those of conventional management mode,and the differences were statistically significant(x2=10.714,8.576,9.756,P<0.05).The recognition scores of the engineers of equipment,doctors,paramedics and managers of relative department for the equipment management of adopting the management mode with risk evaluation system were respectively(92.14±4.01),(93.54±4.63),(93.65±3.36)and(91.57±3.98)points,which were all higher than these of adopting conventional management mode,and the differences were statistically significant(t=15.798,13.331,15.545,13.940,P<0.05).The average value of qualified rate of threshold value of equipment alarm,and that of operation and maintenance of equipment of adopting the management mode with risk evaluation system were respectively(98.25±3.54)%and(97.36±4.65)%,which were higher than those of the conventional management mode,and the average value of alarm silence rate of the management mode with risk evaluation system was(2.36±1.54)%,which was lower than that of conventional management mode,and the differences were statistically significant(t=11.207,8.813,10.717,P<0.05).Conclusion:The application of the risk evaluation system for safe operation of medical equipment of the department of pediatrics on the basis of comprehensive weight in the management for equipment can enhance the safety of operating equipment,and reduce the risk of using equipment,and improve the quality of managing equipment.
6.Visual analysis of clinical study on Chinese medicine treatment of polycystic ovary syndrome
Ruiya HUANG ; Xueqin PENG ; Wenxin LYU ; Tingting ZHAI
China Modern Doctor 2025;63(7):5-10
Objective Based on metrology analysis of the literatures on the treatment of polycystic ovary syndrome(PCOS)by traditional Chinese medicine,the research trends,hot spots and current situation in this field in the past 10 years were discussed,so as to provide reference for future clinical application and academic research.Methods Clinical research literatures on the treatment of PCOS by traditional Chinese medicine published on CNKI,Wanfang Data Knowledge Service Platform and VIP database from January 2014 to October 2024 were searched.CiteSpace software was used to visualize the knowledge graph of authors,institutional cooperation,key words and other relevant data.Results A total of 1154 Chinese literatures were obtained through the search.The visual analysis found that the traditional Chinese medicine research of PCOS was mainly represented by Hou Lihui and Xu Fang,and the institutions were concentrated in the universities of traditional Chinese medicine and their affiliated hospitals in Northeast and East China.The key words analysis showed that infertility,obesity,insulin resistance,intestinal flora,metabolomics and other research hots pots in this field.Conclusion Chinese medicine has significant efficacy in treatment of PCOS,and its holistic regulation theory is highly compatible with the systemic metabolic disorder of PCOS.However,existing studies are characterized by regional concentration,and cross-regional cooperation and disciplinary integration need to be strengthened.Future studies should focus on multidisciplinary comprehensive treatment combining Chinese and Western medicine to promote the modernization and precision of PCOS treatment.
7.Clinical analysis of donor-purified CD34 + stem cell boost in 11 patients with poor hematopoietic reconstruction after haploid hematopoietic stem cell transplantation for aplastic anemia
Yun HE ; Zhengli XU ; Huan CHEN ; Yao CHEN ; Tingting HAN ; Yuanyuan ZHANG ; Meng LYU ; Xiaodong MO ; Chenhua YAN ; Yu WANG ; Yuqian SUN ; Xiaohui ZHANG ; Xiaojun HUANG ; Lanping XU
Chinese Journal of Hematology 2025;46(7):618-624
Objective:To evaluate the safety and efficacy of donor-purified CD34 + stem cell boosts in patients with poor hematopoietic reconstruction (PHR) after haploid hematopoietic stem cell transplantation (haplo-HSCT) for aplastic anemia (AA) . Method:A retrospective analysis was conducted on 11 patients with AA and PHR who underwent haplo-HSCT and received donor-purified CD34 + stem cell boosts at Peking University People’s Hospital. Recovery of blood cell counts, incidence of graft-versus-host disease (GVHD), and overall survival (OS) were assessed. Results:Of the 11 patients with PHR, two were diagnosed with prolonged isolated thrombocytopenia (PT), one was primary poor graft function (PGF), and eight were diagnosed with secondary PGF. The median time to PHR diagnosis was 110 days (range: 60-330 days), and the median interval from transplantation to purified CD34 + hematopoietic stem cell infusion was 194 days (range: 125-456 days). The two patients with PT achieved complete platelet recovery at 22 and 13 days after CD34 + stem cell infusion, respectively. Among the remaining nine patients with PGF, six achieved complete hematopoietic recovery, with a median absolute neutrophil count recovery time of 19 days (8-158 days), HGB recovery time of 32.5 days (range: 13-158 days), and platelet recovery time of 31.5 days (range: 7-171 days). The incidence of chronic GVHD after infusion was 18.2%, with no cases of acute GVHD observed. The OS rate was 90.9% (10/11) in the 11 patients, with a median follow-up of 614 days (range: 153-1 765 days) . Conclusion:Donor-purified CD34 + stem cell boost may be an effective therapeutic strategy for PHR in patients with AA after haplo-HSCT.
8.Serum Dickkopf-related protein 3 and its correlation with sarcopenia phenotypes in elderly individuals
Tingting TANG ; Qianjin SHEN ; Weilin SHI ; Ye HUANG ; Yifan LYU ; Shan LYU
Chinese Journal of Geriatrics 2025;44(12):1733-1740
Objective:To investigate the diagnostic potential of serum Dickkopf-related protein 3(Dkk3)as a novel biomarker for sarcopenia in an elderly Chinese population by examining its correlation with muscle mass, muscle strength, and physical function.Methods:The study included elderly individuals aged ≥60 years from the Health Examination Center of Jiangsu Provincial Hospital between 2021 and 2022, who had independent mobility and were free from acute diseases.Fat and muscle mass were measured using Dual-energy X-ray Absorptiometry(DXA). Grip strength and chair stand test times were employed to assess upper and lower limb muscle strength, respectively.Physical function was evaluated using the Short Physical Performance Battery(SPPB). Serum Dkk3 concentration was measured using a human Dkk3 enzyme-linked immunosorbent assay(ELISA)kit.Results:A total of 108 elderly participants(83 males)were included in the study, with an age range of 60 to 97 years(mean age: 70.6±10.8). Serum Dkk3 concentration was found to be negatively correlated with the skeletal muscle mass index(SMI)( R=-0.292, P=0.002), lower limb muscle mass( R=-0.320, P<0.001), upper limb muscle mass( R=-0.222, P=0.020), and hip muscle mass( R=-0.261, P=0.006). Functional assessments revealed negative correlations with grip strength( R=-0.204, P=0.035), 4-meter walking speed( R=-0.195, P=0.043), the three-position balance test( R=-0.245, P=0.011), and the SPPB score( R=-0.196, P=0.043). Regression analysis indicated that, after adjusting for age, sex, body mass index(BMI), and comorbidities, Dkk3 remained negatively associated with lower limb muscle mass( β=-0.197, P=0.012), hip muscle mass( β=-0.156, P=0.029), and the SPPB score( β=-0.001, P=0.013). The sarcopenia group exhibited a 55.6% higher serum Dkk3 level compared to the control group(76.68±37.62 ng/ml vs.49.27±25.88 ng/ml, P<0.001). Receiver Operating Characteristic(ROC)curve analysis determined the optimal diagnostic threshold to be 80.08 ng/ml, with an area under the curve of 0.726, a sensitivity of 41.98%, and a specificity of 96.30% for detecting sarcopenia. Conclusions:Serum Dkk3 is closely associated with reduced muscle mass in the lower limbs and hips, as well as a decline in physical function, in elderly individuals with sarcopenia.Given its cost-effectiveness and clinical utility, serum Dkk3 shows potential as a meaningful biomarker for diagnosing sarcopenia in the elderly.
9.Efficacy of pudendal nerve modulation in the treatment of female pudendal neuralgia
Ziqin ZHOU ; Xin SONG ; Yinjun GU ; Tingting LYU ; Weilin FANG ; Jin HUANG ; Jianwei LYU ; Zhikang CAI ; Zhong WANG
Journal of Modern Urology 2025;30(5):395-399
Objective: To investigate the clinical efficacy and safety of pudendal nerve modulation (PNM) in the treatment of female pudendal neuralgia (PN),so as to promote the clinical application of this technique. Methods: A retrospective analysis was conducted on 20 female PN patients who failed conservative treatment at Gongli Hospital during Nov.2020 and Oct.2023.All patients underwent simultaneous PNM and sacral nerve modulation (SNM) with the assistance of 3D printing navigation.Dual-stage test electrodes for PNM and SNM were implanted,followed by alternate therapeutic trial for each modality.Secondary conversion rates and longitudinal outcomes,including visual analogue score (VAS),patient health questionnaire-9 (PHQ-9),and quality of life (QoL) scores were compared preoperatively,post-stage Ⅰ,and at 3,6,and 12 months post-stage Ⅱ. Results: All operations were successful.After the trial phase,the secondary conversion rate for PNM was significantly higher than that for SNM; 16 patients (16/20,80%) chose the second-phase PNM implantation surgery,3 (3/20,15%) chose second-phase SNM implantation,and 1 (1/20,5%) had electrodes removed due to ineffective results from both trials.Further assessment revealed that the improvements in VAS,PHQ-9,and QoL scores for PNM patients were significantly better than those for SNM patients after the first phase of surgery and at 3,6 and 12 months after the second-phase conversion (P<0.05).No complications such as electrode migration or infection were observed during the follow-up of 12-15 months. Conclusion: PNM provides more effective relief of pain symptoms and improvements in depressive states for female PN patients compared to SNM.With the assistance of 3D printing navigation,the operation is simple and safe,and offers stable therapeutic effects.It is worthy of clinical promotion and application.
10.Platelet-rich plasma in the treatment of interstitial cystitis/bladder pain syndrome:a single-center prospective study
Jin HUANG ; Rong LYU ; Wenjun MENG ; Tingting LYU ; Weilin FANG ; Jianwei LYU
Journal of Modern Urology 2025;30(12):1043-1048
Objective To investigate the clinical efficacy of platelet-rich plasma (PRP) therapy for interstitial cystitis/bladder pain syndrome (IC/BPS). Methods This single-center prospective study involved 97 IC/BPS patients treated in our hospital during Sep.2023 and Apr.2025, who underwent transurethral bladder injection of PRP. The injections were administered once a month for four sessions. The global response assessment (GRA) score,24-hour urinary frequency, maximum single voiding volume, visual analogue scale (VAS) score, O'Leary score, pelvic pain, urgency and frequency (PUF) score, and Zung self-rating anxiety scale (SAS) score were analyzed. Results All 97 patients completed four injections. The GRA score,24-hour urinary frequency, VAS score, O'Leary score and PUF score were improved significantly after treatment (P<0.007). Intraoperative bladder capacity with significant improvement were observed after the first injection (P<0.01), and the maximum urine output were observed after the fourth injection (P<0.007). The SAS score was not significantly improved. Conclusion Repeated PRP injections can effectively alleviate bladder pain, improve frequent and urgent urination symptoms, and increase the bladder capacity.

Result Analysis
Print
Save
E-mail